Non-Human Primate (NHP) In Vitro & Ex Vivo Research Lab

Q: How do you ensure the quality and consistency of your data?

Creative Biolabs adheres to rigorous SOPs and a comprehensive quality management system. Our platforms are maintained and operated by a highly experienced team of scientists, ensuring data reproducibility and reliability for your most critical studies.

Are you currently facing challenges in bridging the gap between preclinical models and human clinical trials? Our NHP In Vitro & Ex Vivo Research Labs Platforms helps you accelerate your drug discovery process and obtain highly predictive data through advanced primary cell and tissue analysis, multi-modal biomarker detection, and an integrated molecular biology core. By providing a comprehensive suite of services, we enable you to gain deeper insights into your therapeutic candidates with increased efficiency and confidence.

NHP In Vitro & Ex Vivo Research Platforms for Translational Studies

Enabling biodistribution tracking, real-time monitoring, and mechanistic insights in primate models.

Introduction to NHP In Vitro & Ex Vivo Research Platforms

What Are Our Platforms?

At Creative Biolabs, our NHP In Vitro & Ex Vivo Research Labs Platforms offer a comprehensive suite of services designed to provide deep mechanistic insights into therapeutic candidates using non-human primate (NHP) models. We move beyond traditional in vivo studies to provide granular, cellular-level data that is highly predictive of human outcomes. Our platforms are essential for drug development programs that require human-relevant data early in the preclinical phase.

Our services are used across various applications, including:

Immunology and Vaccine Development: Analyzing immune cell responses and cytokine profiles to evaluate vaccine efficacy and immune-modulating drugs.
Pharmacokinetics and Pharmacodynamics (PK/PD): Assessing drug distribution, metabolism, and on-target effects in complex tissue and cell systems.
Gene and Cell Therapy: Monitoring gene delivery, expression, and long-term cellular effects in a model that closely mimics human physiology.

Why Choose Our Platforms?

The translational gap between small animal models and human clinical trials is a major challenge in drug development, leading to high failure rates and significant costs. Creative Biolabs' platforms address this pain point by leveraging the genetic and physiological similarities of NHPs to humans, offering an unparalleled level of predictive power. This value proposition translates to tangible benefits for our clients: reduced R&D uncertainty, accelerated timelines for regulatory submissions, and a higher probability of success in human trials. By providing early access to high-quality, human-relevant data, we empower you to make more informed decisions and de-risk your program from the start.

Key Benefits of Our Platforms

Data highly predictive of human outcomes.
Comprehensive multi-modal platform integration.
Supports a wide range of therapeutic areas.
Accelerates IND submission timelines.

Core Capabilities of Our Platforms

Primary Cell Isolation & Culture: Enabling functional assays with fresh, high-viability NHP immune and parenchymal cells.
Precision-Cut Tissue Slice (PCTS) Workshops: Providing a unique ex vivo model for metabolism, toxicology, and drug distribution studies in intact tissue.
High-Throughput Flow Cytometry Suite: Quantifying cell populations and signaling pathways with speed and precision for immunology and oncology research.
Multiplex Immunoassay Platforms: Simultaneously measuring dozens of biomarkers, cytokines, and proteins from a single sample using advanced multiplex and ultrasensitive immunoassay technologies to generate comprehensive biological profiles.
Molecular Biology Core (qPCR, ddPCR, NGS): Analyzing gene expression, viral load, and genetic modifications with advanced qPCR, ddPCR, and next-generation sequencing.

Applications Enabled

Assessing the biodistribution and on-target effects of gene therapies.
Analyzing immune responses to biologics and cell-based therapies.
Evaluating drug safety and toxicity in ex vivo tissue models.
Characterizing host-pathogen interactions for infectious disease research.

Deliverables

Raw data files (e.g., flow cytometry FCS files, NGS FASTQ files).
Processed datasets and statistical analysis reports.
Detailed study reports with comprehensive methodology and findings.
QC logs, metadata (species, donor info), and sample tracking records.

Frequently Asked Questions

Q: What is the key advantage of using in vitro and ex vivo NHP models over traditional in vivo studies?

A: Our platforms provide a more controlled environment for precise mechanistic studies and can reduce the number of animals required, saving time and resources. They offer a powerful complement to in vivo work, giving you a deeper understanding of drug effects at the cellular and molecular level.

Q: How do you ensure the quality and consistency of your data?

A: Creative Biolabs adheres to rigorous SOPs and a comprehensive quality management system. Our platforms are maintained and operated by a highly experienced team of scientists, ensuring data reproducibility and reliability for your most critical studies.

Q: Can you customize your platforms to fit my specific research needs?

A: Absolutely. Our team of experts will work closely with you to design a tailored study plan that meets your unique objectives. From custom panel design for flow cytometry to developing new assays, we are committed to providing flexible solutions.

Q: What types of samples can you analyze?

A: Our platforms are compatible with a wide range of NHP sample types, including peripheral blood mononuclear cells (PBMCs), isolated tissue slices, plasma, and serum. We can accommodate various sample matrices to provide a complete picture of your therapeutic candidate's effects.

Q: How do your platforms support IND-enabling studies?

A: Our data is generated with the highest standards of quality and traceability, making it suitable for regulatory submissions. The predictive power of our NHP models and the detailed, quantitative data we provide can significantly strengthen your application and accelerate your path to the clinic.

Contact Us

Creative Biolabs' NHP In Vitro & Ex Vivo Research Labs Platforms offer the precision and predictive power needed to accelerate your journey from discovery to the clinic. Ready to leverage our platforms for your next study? Contact our team for more information and to discuss your project. We invite you to explore how our expertise can advance your research goals.